A recent study showed that U2AF1 is a haplo-essential oncogene for mouse hematopoietic cancer cell survival and U2AF1 mutations are always heterozygous with the residual WT allele. Here, U2AF1 is linked to hematopoietic and lymphoid cell neoplasm.